Jay Cutler and TRT: How a Regular Patient Would Get Access to Testosterone Replacement Therapy

What Jay Cutler Has Said About His TRT Use

Jay Cutler, who won the Mr. Olympia title four times between 2006 and 2010, has been candid about his transition to testosterone replacement therapy after stepping away from competitive bodybuilding. In podcast appearances and Instagram posts, Cutler has described TRT as part of his post-competition health management, distinguishing the therapeutic doses he now uses from the supraphysiological protocols common in elite bodybuilding.

Cutler's Public Statements

Cutler has stated in interviews that his current testosterone use is physician-supervised and aimed at maintaining normal physiological levels rather than building stage-ready muscle mass. This is a meaningful distinction. Competitive bodybuilders frequently use testosterone at doses of 500 mg per week or higher, often stacked with other anabolic compounds. TRT, by contrast, targets the reference range of 300 to 1,000 ng/dL established by the American Urological Association [1].

Why Retired Bodybuilders Often Need TRT

Long-term exogenous androgen use suppresses the hypothalamic-pituitary-gonadal (HPG) axis. A 2021 review published in Reviews in Endocrine and Metabolic Disorders found that prior anabolic steroid users demonstrated persistent hypogonadism in a significant proportion of cases, with recovery of endogenous testosterone production taking months to years, and sometimes never fully occurring [2]. For someone like Cutler, who competed at the highest level for over a decade, medically supervised TRT addresses a well-documented physiological consequence of that career.

It is worth separating what Cutler does from what a first-time patient would experience. Cutler's medical history, prior androgen exposure, and relationship with specialized physicians give him a different starting point than someone walking into a clinic for the first time.

Who Qualifies for TRT: The Clinical Criteria

The path to a TRT prescription begins with meeting specific diagnostic thresholds. You cannot simply request testosterone because you feel tired. The Endocrine Society's 2018 clinical practice guideline defines male hypogonadism as "a clinical syndrome that results from failure of the testis to produce physiological levels of testosterone and a normal number of spermatozoa" [3].

Diagnostic Requirements

Two components must be present for a diagnosis:

1. Biochemical confirmation. At least two morning (before 10 AM) serum total testosterone measurements below 300 ng/dL. Morning sampling is required because testosterone follows a circadian rhythm, peaking between 6 AM and 8 AM [3].

2. Consistent symptoms. These include reduced sexual desire, erectile dysfunction, decreased energy, loss of body hair, reduced muscle mass, increased body fat, depressed mood, or anemia of unexplained origin.

A single low reading is not sufficient. The AUA's 2018 guideline similarly requires confirmatory testing and states that total testosterone below 300 ng/dL on two occasions is the threshold for considering treatment [1].

What Disqualifies a Patient

Not everyone with low testosterone is a candidate. The Endocrine Society recommends against initiating TRT in men who are actively trying to conceive (testosterone suppresses spermatogenesis), men with untreated severe obstructive sleep apnea, men with uncontrolled heart failure, and men with a hematocrit above 50% [3]. Prostate cancer history was once considered an absolute contraindication. Current evidence has shifted this stance, but active, untreated prostate cancer remains a reason to withhold therapy [4].

Step-by-Step: How a Regular Patient Gets TRT

For someone without Cutler's medical background, the process is straightforward but involves several clinical checkpoints. Here is what a typical pathway looks like.

Step 1: Initial Consultation and Symptom Assessment

A patient presents to a primary care physician, urologist, or endocrinologist with symptoms suggestive of low testosterone. The provider takes a detailed history covering sexual function, energy, mood, and body composition changes. Screening questionnaires like the Androgen Deficiency in the Aging Male (ADAM) questionnaire may be used, though their sensitivity and specificity are limited [5].

Step 2: Laboratory Workup

The provider orders a morning total testosterone level. If the first result falls below 300 ng/dL, a second confirmatory draw is scheduled on a separate day. Additional labs typically include free testosterone (calculated or measured by equilibrium dialysis), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, complete blood count (CBC), comprehensive metabolic panel, lipid panel, and prostate-specific antigen (PSA) [1].

LH and FSH levels help distinguish primary hypogonadism (testicular failure, with elevated gonadotropins) from secondary hypogonadism (pituitary or hypothalamic dysfunction, with low or inappropriately normal gonadotropins). This distinction matters for treatment planning and for identifying underlying causes such as pituitary tumors.

Step 3: Shared Decision-Making and Prescription

If labs and symptoms align, the provider discusses treatment options, risks, and monitoring requirements. The 2018 AUA guideline states: "Clinicians should inform testosterone deficient patients of the absence of evidence linking testosterone therapy to the development of prostate cancer" [1]. The conversation should also address potential effects on fertility, erythrocytosis risk, and the commitment to ongoing monitoring.

Once the patient and provider agree to proceed, testosterone is prescribed. Because testosterone is a Schedule III controlled substance under federal law, prescriptions require a DEA-registered provider and cannot be refilled indefinitely without follow-up visits [6].

Step 4: Ongoing Monitoring

The Endocrine Society recommends checking testosterone levels, hematocrit, and PSA at 3 to 6 months after starting therapy, then annually [3]. Hematocrit monitoring is particularly important. A 2017 pharmacovigilance study published in PLOS ONE found that testosterone therapy increased hematocrit by an average of 3.2% over 12 months, with 11.2% of patients exceeding the 54% threshold that triggers dose adjustment or phlebotomy [7].

Dr. Shalender Bhasin, a professor of medicine at Harvard Medical School and lead author of the TRAVERSE trial, has noted: "The goal of testosterone treatment is to restore testosterone levels to the mid-normal range, not to push levels to the upper end or above the normal range" [8].

Available TRT Formulations

The testosterone Cutler uses is almost certainly an injectable formulation, the most common form among former bodybuilders. But patients today have several FDA-approved options.

Injectable Testosterone

Testosterone cypionate and testosterone enanthate are the most prescribed forms. Both are intramuscular or subcutaneous injections, with cypionate being the more common in the United States. Typical doses are 100 to 200 mg every one to two weeks, though many clinicians now favor smaller, more frequent doses (50 to 80 mg twice weekly) to minimize peak-and-trough fluctuations [3]. Generic testosterone cypionate 200 mg/mL costs approximately $30 to $90 per 10 mL vial, which lasts most patients 10 to 20 weeks.

Transdermal Options

Topical gels (AndroGel, Testim, Vogelxo) deliver 50 to 100 mg of testosterone daily through the skin. They produce steadier serum levels but carry a risk of transference to household contacts. The FDA requires a black box warning about secondary exposure, particularly to children and women [9]. Gels cost $200 to $500 per month at brand pricing, though generics and manufacturer coupons can reduce this significantly.

Oral Testosterone

Testosterone undecanoate (Jatenzo), approved by the FDA in 2019, is the first oral testosterone that avoids first-pass liver toxicity through lymphatic absorption [10]. Dosing is 158 to 396 mg twice daily with food. It is more expensive than injectables, often exceeding $500 per month without insurance coverage.

Nasal and Pellet Options

Nasal testosterone (Natesto) delivers 11 mg per dose, applied three times daily. Subcutaneous pellets (Testopel) are implanted every 3 to 6 months in an office procedure. Both have niche roles but are less commonly prescribed than injections or gels.

Telehealth TRT Clinics vs. Traditional Providers

The rise of direct-to-consumer telehealth has changed how many men access TRT. Dozens of online clinics now offer testosterone prescriptions after a virtual consultation and at-home blood draw. This is how access has expanded, but it is also where clinical variability becomes a concern.

What Telehealth Clinics Do Well

Convenience and speed are real advantages. Many clinics ship testing kits to patients, offer video consultations within days, and deliver medications by mail. For men in rural areas or those without easy access to endocrinologists, these services fill a genuine gap.

Where the Risks Lie

A 2022 cross-sectional study in JAMA Internal Medicine evaluated 50 direct-to-consumer testosterone websites and found that only 43% mentioned the need for two confirmatory low testosterone levels before prescribing, and just 37% discussed fertility effects [11]. Some clinics prescribe testosterone at doses that exceed standard TRT ranges, or they bundle testosterone with ancillary drugs like anastrozole (an aromatase inhibitor) or human chorionic gonadotropin (hCG) without strong evidence supporting routine use of these additions in standard TRT.

The Endocrine Society does not recommend routine estradiol monitoring or aromatase inhibitor use in men on TRT [3]. Yet many men's health clinics include these as standard protocol, adding cost without established benefit.

Choosing a Provider

A good provider, whether in-person or telehealth, will require confirmatory labs before prescribing, explain the risks of erythrocytosis and fertility suppression, schedule regular follow-up bloodwork, and adjust doses based on trough testosterone levels rather than peak levels. If a clinic promises testosterone without lab work, or prescribes based on a single test result, that is a red flag.

What TRT Does and Does Not Do

Cutler's physique at age 50-plus is impressive, but TRT alone does not produce it. This distinction matters for patients who see a celebrity endorsement and form unrealistic expectations about what therapeutic testosterone will accomplish.

Documented Benefits

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older with testosterone levels below 275 ng/dL, demonstrated that one year of testosterone gel improved sexual function (as measured by the Psychosexual Daily Questionnaire, P<0.001), increased 6-minute walking distance by 33 meters more than placebo, and improved mood as measured by the PHQ-9 depression scale [12]. Bone mineral density in the spine increased by 7.5% compared to placebo over 12 months in the bone substudy [13].

What TRT Will Not Do

TRT at physiological doses will not produce the muscular development seen in competitive bodybuilding. A 1996 landmark study by Bhasin et al. In the New England Journal of Medicine showed that 600 mg of testosterone enanthate weekly (roughly 3 to 6 times a standard TRT dose) combined with resistance exercise increased fat-free mass by 6.1 kg over 10 weeks [14]. Standard TRT doses of 100 to 200 mg per week produce far more modest body composition changes.

The TRAVERSE Safety Data

The TRAVERSE trial (Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men), published in 2023 in the New England Journal of Medicine, enrolled 5,246 men aged 45 to 80 with hypogonadism and preexisting or high risk for cardiovascular disease. Over a mean follow-up of 33 months, testosterone therapy did not increase the incidence of major adverse cardiovascular events compared to placebo (hazard ratio 0.96, 95% CI 0.78 to 1.17) [8]. This trial resolved years of uncertainty following a 2010 Testosterone in Older Men with Mobility Limitations (TOM) trial that was stopped early due to a higher rate of cardiovascular events in the testosterone group [15].

Cost and Insurance Realities

Price is often the deciding factor in how a patient accesses TRT.

Generic Injectables

Generic testosterone cypionate is among the least expensive prescription medications in the United States. GoodRx data shows prices ranging from $20 to $90 for a 10 mL vial (200 mg/mL) at retail pharmacies. Most commercial insurance plans cover injectable testosterone for diagnosed hypogonadism with prior authorization.

Brand-Name Products

Brand formulations carry significantly higher costs. AndroGel 1.62% runs $500 to $700 per month without insurance. Jatenzo exceeds $500 monthly. Insurance coverage varies, and many plans require step therapy (trying a generic injectable first) before covering brand alternatives.

Clinic Markup

Direct-to-consumer clinics charge $100 to $300 per month for bundled services that typically include the medication, lab monitoring, and consultations. Some of this markup pays for convenience. Some pays for ancillary medications of questionable necessity. Patients should compare total annual cost against the option of a standard physician visit plus generic prescription plus independent lab work, which can total $400 to $800 per year.

The Gap Between Celebrity Access and Patient Access

Jay Cutler's access to TRT is shaped by his decades-long relationships with sports medicine physicians, his public platform, and his financial resources. A regular patient follows a more structured clinical pathway, but the medication itself is the same. There is no special version of testosterone available to celebrities.

The real gap is in monitoring intensity, dose customization speed, and access to specialists. Cutler likely has bloodwork drawn monthly or more frequently, with rapid dose adjustments. The average patient on TRT sees a provider every 3 to 6 months and may wait weeks for lab results and prescription changes. This difference in follow-up cadence, not the drug itself, is where celebrity healthcare diverges most from standard care.

Patients who want a higher standard of monitoring can request more frequent lab draws (most insurance covers quarterly testosterone and CBC panels for the first year) and should track their own symptoms between visits using standardized tools like the qADAM questionnaire [16].